regenerative medicine

People who develop Parkinson’s disease before age 50 may have been born with disordered brain cells that went undetected for decades, research from Cedars-Sinai Medical Center suggests. The study reports on a drug that potentially might help correct these disease processes. Although most Parkinson’s patients are 60 or older when they are diagnosed, about 10%… Read more

A biodegradable nerve guide filled with growth-promoting protein that can regenerate long sections of damaged nerves, without the need for transplanting stem cells or a donor nerve has been developed by University of Pittsburgh School of Medicine researchers. “We’re the first to show a nerve guide without any cells was able to bridge a large… Read more

A new cell therapy enhanced memory and prevented seizures in mice after traumatic brain injury, researchers from the University of California, Irvine report[1]. The researchers transplanted embryonic progenitor cells capable of generating inhibitory interneurons, a specific type of nerve cell that controls the activity of brain circuits, into the brains of mice with traumatic brain… Read more

It’s the promise of stem cell medicine: Someday soon, clinics will rebuild diseased or broken hearts, kidneys, pancreases or blood by growing and reprogramming human cells, then adding them back to the bodies of the patients they came from. If only it were that easy. After two decades of human stem cell research, researchers have… Read more

A group of proteins that help to regenerate damaged nerve cells has been identified by scientists at the German Center for Neurodegenerative Diseases (DZNE). It is commonly accepted that neurons of the central nervous system shut down their ability to grow when they no longer need it; this occurs normally after they have found their… Read more